High diversity of group A streptococcal emm types in an Indian community: The need to tailor multivalent vaccines

Clinical Infectious Diseases

Volumn 40, Issue 1, 2005, Pages 46-51

  Dey, Nilay ^a   McMillan, David J ^c   Yarwood, Penny J ^c   Joshi, R M ^b   Kumar, Rajesh ^a   Good, Michael F ^c   Sriprakash, Kadaba S ^c   Vohra, Harpreet ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; M PROTEIN; STREPTOCOCCUS VACCINE;

ADOLESCENT; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CHILD; COMMUNITY; COMPLEMENT FIXATION; CONTROLLED STUDY; DRUG DESIGN; EMM GENE; ETHNOLOGY; GENE SEQUENCE; HUMAN; MOLECULAR CLONING; MORBIDITY; MORTALITY; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SEQUENCE ANALYSIS; SEROPREVALENCE; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A; VACCINATION;

BACTERIAL TYPING TECHNIQUES; BACTERIAL VACCINES; GENES, BACTERIAL; HUMANS; INDIA; POPULATION GROUPS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; VACCINES, SYNTHETIC; VARIATION (GENETICS);

EID: 11144231662     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/426443     Document Type: Article

References (19)

1. Cunningham, MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13:470-511.
2. Beachey EH, Seyer JM, Dale JB, Simpson WA, Kang AH. Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature 1981; 292:457-9.
3. Bessen D, Fischetti VA. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 1990; 145:1251-6.
4. Facklam R, Martin DR, Lovgren M, et al. Extension of the Lancefield classification for Group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm122. Clin Infect Dis 2002; 34:28-38.
5. Pruksakorn S, Sittisombut N, Phornphutkul C, Pruksachatkunakorn C, Good MF, Brandt E. Epidemiological analyses of non-M-typeable group A Streptococcus isolates from a Thai population in northern Thailand. J Clin Microbiol 2000; 38:1250-4.
6. Teixeira LM, Barros RR, Castro AC, et al. Genetic and phenotypic features of Streptococcus pyogenes strains isolated in Brazil that harbor new emm sequences. J Cin Microbiol 2001; 39:3290-5.
7. Brandt ER, Sriprakash KS, Hobb RI, et al. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat Med 2000; 6:455-9.
8. Hu MC, Walls MA, Stroop SD, et al. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 2002; 70:2171-7.
9. Padmavati S. Rheumatic fever and rheumatic heart disease in developing countries. Bull World Health Organ 1978; 56:543-50.
10. Johnson, DR, Kaplan EL. Microtechnique for serum opacity factor characterization of group A Streptococcus adaptable to the use of human sera. J Clin Microbiol 1988; 26:2025-30.
11. Gardiner D, Hartas J, Currie B, Mathews JD, Klemp DJ, Sriprakash KS. Vir typing: a long type PCR typing method for group A streptococci. PCR Methods Appl 1995; 4:288-92.
12. Gardiner DL, Goodfellow AM, Martin DR, Sriprakash KS. Group A streptococcal Vir types are M-protein gene (emm) sequence type specific. J Clin Microbiol 1998; 36:902-7.
13. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166:374-82.
14. Kim SJ, Kim EC, Cha SH, Kaplan EL. Comparison of M-serotypes of Streptococcus pyogenes isolated from healthy elementary school children in two rural areas. J Korean Med Sci 1996; 11:133-6.
15. Mejia LM, Stockbauer KE, Pan X, Cravioto A, Musser JM. Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein. J Clin Microbiol 1997; 35:3220-4.
16. Nguyen L, Levy D, Ferroni A, Gehanno P, Berche P. Molecular epidemiology of Streptococcus pyogenes in an area where acute pharyngotonsillitis is endemic. J Clin Microbiol 1997; 35:2111-4.
17. Gardiner DL, Sriprakash KS. Molecular epidemiology of indigenous group A streptococcal infections in aboriginal communities of northern Australia. J Clin Microbiol 1996; 34:1448-52.
18. Dale JB. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine 1999; 17:193-200.
19. Kaplan E, Wotton JT, Johnson DR. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngytis. Lancet 2001; 358:1334-7.